Zydus Launches Semaglutide Injection in an Innovative, Reusable Multi-Dose Pen Device in India

Mar 21, 2026

Ahmedabad (Gujarat) [India], March 21: Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as "Zydus"), an innovation-led global lifesciences company, has launched Semaglutide...

Novo Nordisk India partners with Emcure Pharma to launch Poviztra® in India

Nov 11, 2025

The collaboration aims to enhance the distribution and marketing of semaglutide for weight loss, particularly through pharmacies and in regions not currently served by...

Medical experts advise on safe insulin injection practices and enhanced care of people with diabetes during COVID

Jan 12, 2021

New Delhi [India], January 12 (ANI/NewsVoir): On the occasion of 99th anniversary of Insulin Injection Day, Forum for Injection Technique & Therapy Expert Recommendations...

COVID-19: Cocktail antibodies injection used first time in Andhra

May 29, 2021

Guntur (Andhra Pradesh) [India], May 29 : Samishta Hospital and Research Institute (SHRI), Guntur has administered cocktail antibodies injection 'Regeneron' to two patients. This...

BD commemorates 10th Anniversary of its Initiative FITTER - Forum for Injection Technique & Therapy Expert Recommendations

Jan 11, 2022

New Delhi/Mumbai [India], January 11 (ANI/NewsVoir): January 11 every year is observed as Insulin Injection Day and January this year marks the 100th Anniversary...

Generic Semaglutide patent expiry opens over Rs 50,000 Crore opportunity for drugmakers: Report

Jan 03, 2026

In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM) growth...